Genor Biopharma Holdings Limited (6998.HK)

HKD 1.66

(-5.68%)

Total Liabilities Summary of Genor Biopharma Holdings Limited

Genor Biopharma Holdings Limited's latest annual total liabilities in 2023 was 256.17 Million CNY , down -17.33% from previous year.
Genor Biopharma Holdings Limited's latest quarterly total liabilities in 2024 Q2 was 210.97 Million CNY , down 0.0% from previous quarter.
Genor Biopharma Holdings Limited reported annual total liabilities of 309.87 Million CNY in 2022, down -16.19% from previous year.
Genor Biopharma Holdings Limited reported annual total liabilities of 369.73 Million CNY in 2021, up 9.93% from previous year.
Genor Biopharma Holdings Limited reported quarterly total liabilities of 210.97 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Genor Biopharma Holdings Limited reported quarterly total liabilities of 268.54 Million CNY for 2023 Q1, down -13.34% from previous quarter.

Annual Total Liabilities Chart of Genor Biopharma Holdings Limited (2023 - 2018)

Historical Annual Total Liabilities of Genor Biopharma Holdings Limited (2023 - 2018)

Year	Total Liabilities	Total Liabilities Growth
2023	256.17 Million CNY	-17.33%
2022	309.87 Million CNY	-16.19%
2021	369.73 Million CNY	9.93%
2020	336.32 Million CNY	-33.71%
2019	507.37 Million CNY	209.27%
2018	164.05 Million CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	210.97 Million CNY	-17.64%
2024 Q2	210.97 Million CNY	0.0%
2023 Q1	268.54 Million CNY	-13.34%
2023 FY	256.17 Million CNY	-17.33%
2023 Q4	256.17 Million CNY	0.0%
2023 Q3	256.17 Million CNY	-4.61%
2023 Q2	268.54 Million CNY	0.0%
2022 Q2	306.2 Million CNY	0.0%
2022 Q1	306.2 Million CNY	-17.18%
2022 Q4	309.87 Million CNY	0.0%
2022 FY	309.87 Million CNY	-16.19%
2022 Q3	309.87 Million CNY	1.2%
2021 FY	369.73 Million CNY	9.93%
2021 Q1	347.38 Million CNY	3.29%
2021 Q4	369.73 Million CNY	0.0%
2021 Q3	369.73 Million CNY	6.43%
2021 Q2	347.38 Million CNY	0.0%
2020 FY	336.32 Million CNY	-33.71%
2020 Q1	533.4 Million CNY	0.0%
2020 Q2	- CNY	-100.0%
2020 Q4	336.32 Million CNY	0.0%
2020 Q3	336.32 Million CNY	0.0%
2019 Q1	- CNY	0.0%
2019 FY	507.37 Million CNY	209.27%
2018 FY	164.05 Million CNY	0.0%

Peer Total Liabilities Comparison of Genor Biopharma Holdings Limited

Name	Total Liabilities	Total Liabilities Difference
Uni-Bio Science Group Limited	152.81 Million HKD	-67.635%
CK Life Sciences Int'l., (Holdings) Inc.	7.05 Billion HKD	96.37%